2017
DOI: 10.1097/sla.0000000000001670
|View full text |Cite
|
Sign up to set email alerts
|

Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection in Patients With Melanoma (SAFE-MILND)

Abstract: Background Minimally invasive inguinal lymph node dissection (MILND) is a novel approach to inguinal lymphadenectomy. SAFE-MILND (NCT01500304) is a multicenter, phase I/II clinical trial evaluating the safety and feasibility of MILND for patients with melanoma in a group of surgeons newly adopting the procedure. Methods Twelve melanoma surgeons from 10 institutions without any previous MILND experience, enrolled patients into a prospective study after completing specialized training including didactic lectur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
29
0
3

Year Published

2017
2017
2021
2021

Publication Types

Select...
5
3

Relationship

2
6

Authors

Journals

citations
Cited by 43 publications
(33 citation statements)
references
References 33 publications
1
29
0
3
Order By: Relevance
“…Replacement of the large inguinal incision by three smaller incisions away from the inguinal skinfold might offer a solution via a minimally invasive technique, namely, videoscopic inguinofemoral lymphadenectomy. This procedure is accompanied by a lower complication rate in other centers and has a comparable oncologic outcome 2527. Because all other adjustments in perioperative care and management have failed, this procedure might be a promising method for reducing wound complications after ILNDs.…”
Section: Discussionmentioning
confidence: 99%
“…Replacement of the large inguinal incision by three smaller incisions away from the inguinal skinfold might offer a solution via a minimally invasive technique, namely, videoscopic inguinofemoral lymphadenectomy. This procedure is accompanied by a lower complication rate in other centers and has a comparable oncologic outcome 2527. Because all other adjustments in perioperative care and management have failed, this procedure might be a promising method for reducing wound complications after ILNDs.…”
Section: Discussionmentioning
confidence: 99%
“…The Safety and Feasibility of Minimally Invasive Inguinal Lymph Node Dissection trial (SAFE-MILND, NCT01500304) is a prospective, multicenter, phase I/II clinical trial in which established melanoma surgeons were trained in a novel procedure, specifically the minimally invasive technique to perform an inguinal lymphadenectomy (MILND) [9, 10]. The primary aim of the trial was to evaluate the safety and feasibility of the MILND in the treatment of melanoma and have been previously published [9, 10].…”
Section: Methodsmentioning
confidence: 99%
“…The primary aim of the trial was to evaluate the safety and feasibility of the MILND in the treatment of melanoma and have been previously published [9, 10]. For this manuscript, we focus on the pre-trial FLS assessment and the relationship of such with certain trial metrics as described below.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The lnrr can also serve as an entry criterion for patients enrolling in randomized controlled trials for adjuvant therapy. Furthermore, as novel surgical approaches such as minimally invasive inguinal lymph node dissection are incorporated into surgical care, reviewing the lnrr of those procedures for comparison with our published lnrrs in a conventional open approach can be used to quickly validate the completeness of the new techniques 14 .…”
Section: Discussionmentioning
confidence: 99%